IXHL Incannex Healthcare Inc.
-
Incannex Healthcare Missed Consensus Estimates
Friday, September 25, 2026 · 12:00 AM ET
Incannex Healthcare (IXHL) reported a loss of $0.14 per share on revenue of $0.00 million for the fiscal fourth quarter ended June 2026. The consensus earnings estimate was $0.13 per share. The company missed consensus estimates by 207.69%.
Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.
Reported Earnings
($0.14)
Earnings Whisper®
—
Consensus Estimate
$0.13
Earnings Surprise
Earnings Growth—
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—
*Reported earnings and revenue figures shown above, and any guidance given, are preliminary and may be updated upon further review.*